XML 38 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
Derivatives Not Designated As Hedging Instrument
On March 31, 2020, the Company entered into an interest rate swap with a notional amount of $200,000 and a ten‑year term to reduce the interest rate risk associated with the Company’s Credit Facility. The interest rate swap is not designated as a hedging instrument for accounting purposes. The Company accounts for the swap as either an asset or a liability on the consolidated balance sheet and carries the derivative at fair value. Gains and losses from the change in fair value are recognized in Other income (expense), net and payments related to the swap are recognized in Interest expense, net in the consolidated statements of operations. For the three and nine months ended September 30, 2020, the Company recorded a gain (loss) of $809 and $(3,365), respectively, in Other income (expense), net, and total payments recognized in Interest expense, net related to the swap were $288 and $398, respectively.
Fair Value
The Company applies the provisions of ASC Topic 820, Fair Value Measurement, for fair value measurements of financial assets and financial liabilities and for fair value measurements of non‑financial items that are recognized or disclosed at fair value in the consolidated financial statements.
The Company’s financial instruments include cash equivalents, account receivables, certain other assets, accounts payable, accruals, certain other current and long‑term liabilities, and long‑term debt.
The carrying values of the Company’s financial instruments excluding long‑term debt approximate their fair value due to the short‑term nature of those instruments. Additionally, as of September 30, 2020 and December 31, 2019, the fair value of the Company’s long‑term debt approximated its carrying value based upon discounted cash flows at current market rates for instruments with similar remaining terms. The Company considers these valuation inputs to be Level 2 inputs in the fair value hierarchy. Considerable judgment is necessary to interpret the market data and develop estimates of fair values. Accordingly, the estimates presented are not necessarily indicative of the amounts at which these instruments could be purchased, sold, or settled.
A financial asset or liability classification is determined based on the lowest level input that is significant to the fair value measurement. The fair value hierarchy consists of the following three levels:
Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.
Level 3 inputs are unobservable inputs based on management’s own assumptions used to measure assets and liabilities at fair value.
The following tables provide the financial assets and financial liabilities carried at fair value measured on a recurring basis:
September 30, 2020Level 1Level 2Level 3Total
Assets:
Money market funds (1)
$30,794 $— $— $30,794 
Total assets$30,794 $— $— $30,794 
Liabilities:
Acquisition contingent consideration (2)
$— $— $5,143 $5,143 
Interest rate swap (3)
— 3,365 — 3,365 
Deferred compensation plan (4)
2,300 — — 2,300 
Cash-settled equity awards (5)
743 — — 743 
Total liabilities$3,043 $3,365 $5,143 $11,551 
December 31, 2019Level 1Level 2Level 3Total
Assets:
Money market funds (1)
$70,000 $— $— $70,000 
Total assets$70,000 $— $— $70,000 
Liabilities:
Acquisition contingent consideration (2)
$— $— $6,599 $6,599 
Deferred compensation plan (4)
2,544 — — 2,544 
Total liabilities$2,544 $— $6,599 $9,143 
(1)Included in Cash and cash equivalents in the accompanying consolidated balance sheets.
(2)Included in Other liabilities, except for current liabilities of $3,583 and $5,100 as of September 30, 2020 and December 31, 2019, respectively, which are included in Accruals and other current liabilities in the accompanying consolidated balance sheets. Acquisition contingent consideration liability is measured at fair value and is based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The valuation of contingent consideration uses assumptions the Company believes would be made by a market participant.
(3)Included in Other liabilities in the accompanying consolidated balance sheet.
(4)Included in Other liabilities, except for current liabilities of $149 and $153 as of September 30, 2020 and December 31, 2019, respectively, which are included in Accruals and other current liabilities in the accompanying consolidated balance sheets.
(5)Included in Accruals and other current liabilities in the accompanying consolidated balance sheet.
The following table is a reconciliation of the changes in fair value of the Company’s financial liabilities which have been classified as Level 3 in the fair value hierarchy for the nine months ended September 30, 2020 and the year ended December 31, 2019.
Nine Months EndedYear Ended
September 30, 2020December 31, 2019
Balance, beginning of year$6,599 $4,316 
Payments(2,034)(2,513)
Addition1,902 4,498 
Reclassification— 180 
Change in fair value(1,340)62 
Foreign currency translation adjustments16 56 
Balance, end of period$5,143 $6,599 
The Company did not have any transfers between levels within the fair value hierarchy.